The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage

Alexander Rühle, Ramon Lopez Perez, Bingwen Zou, Anca Ligia Grosu, Peter E. Huber, Nils H. Nicolay

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Chemotherapy constitutes one of the key treatment modalities for solid and hematological malignancies. Albeit being an effective treatment, chemotherapy application is often limited by its damage to healthy tissues, and curative treatment options for chemotherapy-related side effects are largely missing. As mesenchymal stromal cells (MSCs) are known to exhibit regenerative capacity mainly by supporting a beneficial microenvironment for tissue repair, MSC-based therapies may attenuate chemotherapy-induced tissue injuries. An increasing number of animal studies shows favorable effects of MSC-based treatments; however, clinical trials for MSC therapies in the context of chemotherapy-related side effects are rare. In this concise review, we summarize the current knowledge of the effects of MSCs on chemotherapy-induced tissue toxicities. Both preclinical and early clinical trials investigating MSC-based treatments for chemotherapy-related side reactions are presented, and mechanistic explanations about the regenerative effects of MSCs in the context of chemotherapy-induced tissue damage are discussed. Furthermore, challenges of MSC-based treatments are outlined that need closer investigations before these multipotent cells can be safely applied to cancer patients. As any pro-tumorigenicity of MSCs needs to be ruled out prior to clinical utilization of these cells for cancer patients, the pro- and anti-tumorigenic activities of MSCs are discussed in detail.

Original languageEnglish (US)
JournalStem Cell Reviews and Reports
DOIs
StatePublished - Jan 1 2019

Fingerprint

Mesenchymal Stromal Cells
Drug Therapy
Therapeutics
Cell- and Tissue-Based Therapy
Clinical Trials
Hematologic Neoplasms
Neoplasms
Wounds and Injuries

Keywords

  • Mesenchymal stromal cells (MSCs)
  • chemotherapy
  • side effects
  • stem cells
  • tumors

ASJC Scopus subject areas

  • Cell Biology
  • Cancer Research

Cite this

The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage. / Rühle, Alexander; Lopez Perez, Ramon; Zou, Bingwen; Grosu, Anca Ligia; Huber, Peter E.; Nicolay, Nils H.

In: Stem Cell Reviews and Reports, 01.01.2019.

Research output: Contribution to journalReview article

Rühle, Alexander ; Lopez Perez, Ramon ; Zou, Bingwen ; Grosu, Anca Ligia ; Huber, Peter E. ; Nicolay, Nils H. / The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage. In: Stem Cell Reviews and Reports. 2019.
@article{90a20596d9454362a28e5f1f08e1ee66,
title = "The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage",
abstract = "Chemotherapy constitutes one of the key treatment modalities for solid and hematological malignancies. Albeit being an effective treatment, chemotherapy application is often limited by its damage to healthy tissues, and curative treatment options for chemotherapy-related side effects are largely missing. As mesenchymal stromal cells (MSCs) are known to exhibit regenerative capacity mainly by supporting a beneficial microenvironment for tissue repair, MSC-based therapies may attenuate chemotherapy-induced tissue injuries. An increasing number of animal studies shows favorable effects of MSC-based treatments; however, clinical trials for MSC therapies in the context of chemotherapy-related side effects are rare. In this concise review, we summarize the current knowledge of the effects of MSCs on chemotherapy-induced tissue toxicities. Both preclinical and early clinical trials investigating MSC-based treatments for chemotherapy-related side reactions are presented, and mechanistic explanations about the regenerative effects of MSCs in the context of chemotherapy-induced tissue damage are discussed. Furthermore, challenges of MSC-based treatments are outlined that need closer investigations before these multipotent cells can be safely applied to cancer patients. As any pro-tumorigenicity of MSCs needs to be ruled out prior to clinical utilization of these cells for cancer patients, the pro- and anti-tumorigenic activities of MSCs are discussed in detail.",
keywords = "Mesenchymal stromal cells (MSCs), chemotherapy, side effects, stem cells, tumors",
author = "Alexander R{\"u}hle and {Lopez Perez}, Ramon and Bingwen Zou and Grosu, {Anca Ligia} and Huber, {Peter E.} and Nicolay, {Nils H.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12015-019-09886-3",
language = "English (US)",
journal = "Stem Cell Reviews and Reports",
issn = "1550-8943",
publisher = "Humana Press",

}

TY - JOUR

T1 - The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage

AU - Rühle, Alexander

AU - Lopez Perez, Ramon

AU - Zou, Bingwen

AU - Grosu, Anca Ligia

AU - Huber, Peter E.

AU - Nicolay, Nils H.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Chemotherapy constitutes one of the key treatment modalities for solid and hematological malignancies. Albeit being an effective treatment, chemotherapy application is often limited by its damage to healthy tissues, and curative treatment options for chemotherapy-related side effects are largely missing. As mesenchymal stromal cells (MSCs) are known to exhibit regenerative capacity mainly by supporting a beneficial microenvironment for tissue repair, MSC-based therapies may attenuate chemotherapy-induced tissue injuries. An increasing number of animal studies shows favorable effects of MSC-based treatments; however, clinical trials for MSC therapies in the context of chemotherapy-related side effects are rare. In this concise review, we summarize the current knowledge of the effects of MSCs on chemotherapy-induced tissue toxicities. Both preclinical and early clinical trials investigating MSC-based treatments for chemotherapy-related side reactions are presented, and mechanistic explanations about the regenerative effects of MSCs in the context of chemotherapy-induced tissue damage are discussed. Furthermore, challenges of MSC-based treatments are outlined that need closer investigations before these multipotent cells can be safely applied to cancer patients. As any pro-tumorigenicity of MSCs needs to be ruled out prior to clinical utilization of these cells for cancer patients, the pro- and anti-tumorigenic activities of MSCs are discussed in detail.

AB - Chemotherapy constitutes one of the key treatment modalities for solid and hematological malignancies. Albeit being an effective treatment, chemotherapy application is often limited by its damage to healthy tissues, and curative treatment options for chemotherapy-related side effects are largely missing. As mesenchymal stromal cells (MSCs) are known to exhibit regenerative capacity mainly by supporting a beneficial microenvironment for tissue repair, MSC-based therapies may attenuate chemotherapy-induced tissue injuries. An increasing number of animal studies shows favorable effects of MSC-based treatments; however, clinical trials for MSC therapies in the context of chemotherapy-related side effects are rare. In this concise review, we summarize the current knowledge of the effects of MSCs on chemotherapy-induced tissue toxicities. Both preclinical and early clinical trials investigating MSC-based treatments for chemotherapy-related side reactions are presented, and mechanistic explanations about the regenerative effects of MSCs in the context of chemotherapy-induced tissue damage are discussed. Furthermore, challenges of MSC-based treatments are outlined that need closer investigations before these multipotent cells can be safely applied to cancer patients. As any pro-tumorigenicity of MSCs needs to be ruled out prior to clinical utilization of these cells for cancer patients, the pro- and anti-tumorigenic activities of MSCs are discussed in detail.

KW - Mesenchymal stromal cells (MSCs)

KW - chemotherapy

KW - side effects

KW - stem cells

KW - tumors

UR - http://www.scopus.com/inward/record.url?scp=85064354750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064354750&partnerID=8YFLogxK

U2 - 10.1007/s12015-019-09886-3

DO - 10.1007/s12015-019-09886-3

M3 - Review article

C2 - 30937640

AN - SCOPUS:85064354750

JO - Stem Cell Reviews and Reports

JF - Stem Cell Reviews and Reports

SN - 1550-8943

ER -